Score Breakdown
Offering Ability
80
Cash Runway
40
Float Risk
100
Warrant Exposure
40
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 49%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 41% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
model est. 55%
• 50-day avg $0.92 below $1 exchange minimum
📉 Score Deterioration
model 15%
• Score already CRITICAL (81/100) — events likely imminent
Market Data
Market Cap$10.56M
Shares Outstanding84.07M
Float3.46M
Cash$13.40M
Debt$956.9K
Short InterestN/A
Institutional Holdings
13.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual MYNZ Dilution Snapshot
Mainz Biomed NV (MYNZ) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for MYNZ: xbrl on 2026-06-30; xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles: